$GME, Short Squeeze Round #2?Right now, I think realistically if the positive social sentiment for GameStop doesn't slow any time soon, it can bypass $275. That said, it is quite risky. I mean extremely risky. This year in general have been different, and it was interesting to see what happened w/ GameStop. That said, please do your own due diligence. Invest at your own risk. Everything I say is on an opinion based basis.
Chartpatternstrading
Is Elon Musk Playing 4-Dimensional Chess w/ BitcoinDoes anybody remember when Elon Musk tweeted, "Tesla stock price is too high, IMO", right before the continuation of one of the biggest historical rallies for a stock? I believe now may be the same case. If you are able to break certain resistance curves with financial assets, then once support quickly adds back towards the smaller dips, it can continue way past its previous price and have barely any resistance. I'm not saying this is what Elon Musk is trying to do, but if he is playing some sort of multidimensional chess game, who can blame him? That said, please do your own due diligence and invest at your own risk. Everything I say is on an opinion based basis.
$EH is a big dip opportunity!While I am not a big fan of autonomous UAVs just yet, I still think a short seller report on a company like EHang was a bit unfair. I disagree with many of the sentiments regarding the report, but time will tell. I am strongly considering an entry position. That said, please do your own due diligence and invest at your own risk. Everything I say is on an opinion based basis.
I am upgrading my $NNOX Target from $115 to $200+I seen what happened at $95, the FDA response, and how people responded to lockup expiration + the secondary offering. People reacted quickly, things got tense, and now the storm will soon calm. The point is, it very recently hit a new high, and a new high will happen likely really soon. Once $115 passes, my new target is $200. I believe this is feasible if single source FDA approval is within a timely manner. They also have factories and deployments. I am looking constantly at institutional activity, and that is what excites me the most trend-wise. That said, please invest at your own risk and do your own due diligence. Everything I say is on an opinion based basis.
$BVS: Bioventus is a $45 TargetI believe the price target for Bioventus can easily be $45. It is a new IPO for a company w/ 700+ employees, disruptive orthobiologics and surgical methods, and high growth potential. Support just needs to pickup. That said, please do your own due diligence and invest at your own risk. Everything I say is on an opinion based basis.
New IPO? $UGROThe low volume on share liquidity seems suspect, but I think as soon as this starts garnishing higher support levels, it may catch the eyes of some institutional investors. Right now, it may be a great early buy opportunity. That said, please do your own due diligence and invest at your own risk.
YUM Brands: Great Earnings, Long Term Hold PotentialYUM brands has been consistently beating earnings and revenue expectations in the past, and is stably growing. I recommend a long hold given support levels + stock correlations. Options are looking tempting. That said, please do your own due diligence and invest at your own risk. Everything I say is on an opinion based basis.
A Buy and Forget? YJI decided to just get Yunjji at a 22% price premium, for various reasons: 1) They have a large membership, and are relatively small for a trending space for investors. 2) Look at the $BABA and $JMIA play. 3) Market cap is only $595.55M, which is relatively small. Anyways, I took a small position in it as I'm cautious, but definitely on the watchlist. That said, do your own due diligence and invest at your own risk. Everything I say is on an opinion based basis.
Wait Until the $15+ Wave: Reiterating LongAgain, I think this is one of the more decent speculative plays or dip opportunities for a swing out there. Shorts are soon going to need to likely cover, you have an RSI less than 30, and people are overreacting to the clinical data and news headlines. The support level just needs to pickup for a really good squeeze. PR could come like a hammer for overly anxious bears. That said, please invest at your own risk and do your own due diligence. Everything I say is on an opinion based basis.
Big Fan of $FLNCF, Could Moon!First off, I know Freelancer may be a bit smaller than Upwork in terms of revenue. However, look at the comparative market caps, employees, and # of users. The TAM potential for Freelancer as a disruptor is huge. It is severely undervalued, and this is more of a marketing problem in my opinion. This could and should easily hit $1, and I think a fair value is actually much higher then that. That said, please do your own due diligence and invest at your own risk. Everything I say is on an opinion based basis.
Two Best Swings of the Day: $VTNR and $FTOCMy two favorite swings for profit turnover today were these two stocks, they also are decent for long term holds. $VTNR though, is at a higher risk position. That said, please do your own due diligence and invest at your own risk.
My Weekly Opportunity WatchlistENVB and AEZS has positive sentiment to pickup, and some people are turning to AEZS out of excitement of a potential VXRT-like rise. DRCB is a decent entry for a long hold or a short term swing. WTI looks like it is going to go up w/ increased demand in gas and was previously oversold prior to picking up support levels. JDST will grow off of precious metals sentiment trending. Everything I'm saying is on an opinion based basis. Please invest at your own risk and do your own due diligence.
Buy @$10, Sell at $15+: Big Dip Opportunity!I wasn't able to get into $VXRT before, and now thanks to a recent market overreaction, I think this is a great dip opportunity and will pickup support levels that will cause a short squeeze soon. RSI shows way oversold, and look at the performance day to day. That said, please invest at your own risk and do your own due diligence. Everything I say is on an opinion based basis.
$BFT Continued Uptrend: TP #1: $25+A special acquisition for a PayPal competitor that has way less of a marketcap, but way higher of a TAM and growth potential opportunity. Sort of reminds me of the $JMIA play in regards to $BABA. Pattern is on an uptrend as well w/ continued support levels and likely positive sentiment. That said, do your own due diligence and invest at your own risk. Everything I say is on an opinion based basis.
Ignore the Downgrades, Ride Past Earnings: Super BullishNone of the fundamentals of $HYLN has changed. In my opinion, it is still close to picking up key support levels. $HYLN has already been oversold, and it has low volume into an earnings call that I believe has some high potential. I would say, buy and hold. This stock should be at the very least $25 if it wasn't for the massive market overreaction. I think the neutral points, upcoming resistance + company fundamentals are promising. That said, do your own due diligence and invest at your own risk.
12 Mid-High Risk Stocks in my 2021 WatchlistThe 12 mid to high risk stocks in my 2021 watchlist include: $ATOM, $ADOM, $NNDM, $BNGO, $PUBM, $UPWK, $BLSP, $RETC, $LGVW, $PSAC, $HYLN, and $NETE. Currently, the ones that excite me the most are: $NNDM, $LGVW, $BLSP, $ATOM and $HYLN. I am also keeping a close watch on the $PSAC spac, which I believe is Faraday Futures. That said, please do your own due diligence and invest at your own risk. Everything I say is on an opinion based basis.
$MARK Long -> $4.41 TargetRemark Holdings may actually be due for a reentry. I do believe that they have been tested multiple times, and it is due for a retest in a positive direction. My current target based on chart correlation is $4.41 as a GTC long entry. That said, this is quite risky as of now. Please do your own due diligence and invest at your own risk. Everything I am saying is on an opinion based basis.
$NNOX, Wait for the Catalyst + Short Squeeze (Low Volume)Nanox has been shortened alot, and now oversold on low volume. Looking at the RSI, it is quite low, and due for a breakout. Outside of this, I believe it has been announced that they have pre-orders for within the range of 15k machines. This accounts to what could be $1 billion in mostly revenue, if I understand currently from what has been said about the JP Morgan Virtual Conference. At the current market cap of $2.3B, this puts them likely under their fair overall enterprise value. Currently, FDA approval is a major catalyst that should be "soon" in regards to single source if everything goes well. Multi-source could be in the first half of 2021. It is currently a waiting game in regards to catalyst. There are also other big catalyst such as a factory announcement that may happen soon. Regarding patterns, I think overall a bullish setup is there. Currently, I am long. That said, do your own due diligence and invest at your own risk.
Long on $SMART EntryCurrently, I believe that Smartcash does have the potential of the next leg/wave up in regards to a positive retracement. Pattern is there, and w/ the current support levels in regards to the crypto market in general, I don't see a reason why the pattern would change. That said, please invest at your own risk and do your own due diligence. Everything I say is on an opinion based basis.
Siacoin is Underrated, Next Wave Up Opportunity!In regards to technical analysis, I seriously believe that Siacoin is underrated and has much higher bull run + gains ROI potential compared to some of its counterparts. This also has to do in part w/ chart patterns, sentiment regarding their network, and the hard fork. The support should pickup, and a retracement wave is possible from the previous bearishness wedge. Please keep in mind, everything I say is on an opinion based basis. Please invest at your own risk and do your own due diligence.
The $115+ NNOX Target + Patterns$NNOX is one of those volatile stocks that took the world by storm. If you don't like volatility, it is likely best to stay away from biotech or healthcare. That said, there are alot of expected catalysts. $NNOX have been heavily shortened, and it is in the opinion of many that lots of market manipulation has been and is going on. The short interest is low and the borrow rate is high. Currently as I see it, the pattern is still incrementally upwards. Nanox has the catalyst of factory announcements, FDA approvals for both single and multisource, plus the commencement of "device leasing". Currently with 4 catalyst, three of them that are expected to be big, a target of $115 seems reasonable. Support levels should be picking up soon, and unless one wants to flip for few cents or dollars per share as profit, this currently seems much better suited for a long term position. That said, I am long. Everything I say is on an opinion based basis. Please do your own due diligence and proceed with caution. Opinions mentioned here aren't meant to warrant solicited financial advice.